Gardasil Use Suggests Need For PDUFA Post-Market Provisions, Senator Says
Executive Summary
The use of Merck's human papilloma virus vaccine Gardasil in girls as young as nine years old underscores the need to apply FDA user fee funds to post-marketing surveillance of products, Sen. Barbara Mikulski, D-Md., said during a Senate Health Committee hearing March 14
You may also be interested in...
Rx Safety Bill Would Require Renegotiation Of User Fees, FDA Tells Senate
An expansion of FDA's drug safety authorities as envisioned by legislation from Sens. Ted Kennedy, D-Mass., and Michael Enzi, R-Wyo., would require a renegotiation of user fees with industry, Commissioner Andrew von Eschenbach said
Rx Safety Bill Would Require Renegotiation Of User Fees, FDA Tells Senate
An expansion of FDA's drug safety authorities as envisioned by legislation from Sens. Ted Kennedy, D-Mass., and Michael Enzi, R-Wyo., would require a renegotiation of user fees with industry, Commissioner Andrew von Eschenbach said
Merck Halts Gardasil Lobbying Efforts Following Discussions With ACIP, AAP
Merck decided to halt lobbying efforts for state legislation requiring vaccination with its human papilloma virus vaccine Gardasil for school entry following discussions with third party stakeholders, including CDC's Advisory Committee on Immunization Practices and the American Academy of Pediatrics, the company said